Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$2.11 | -$2.11 | -$2.11 |
| Q2 2026 | 2 | -$1.92 | -$1.92 | -$1.92 |
| Q3 2026 | 2 | -$1.77 | -$1.77 | -$1.77 |
| Q4 2026 | 1 | -$1.83 | -$1.83 | -$1.83 |
| Q1 2027 | 1 | -$2.18 | -$2.18 | -$2.18 |
| Q2 2027 | 1 | -$2.35 | -$2.35 | -$2.35 |
| Q3 2027 | 1 | -$2.51 | -$2.51 | -$2.51 |
| Q4 2027 | 1 | -$2.69 | -$2.69 | -$2.69 |
Nextcure Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-1.87 earnings per share for the quarter, missing analysts' consensus estimates of $-1.81 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Nextcure Inc has generated $-20 earnings per share over the last year ($-19.65 diluted earnings per share) and currently has a price-to-earnings ratio of -0.09. Nextcure Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$1.81 | -$1.87 | -0.06 | $0 | $0 |
| 03/05/2026 | Q4 2025 | -$2.26 | -$2.69 | -0.43 | $0 | $0 |
| 11/05/2025 | Q3 2025 | -$4.06 | -$3.22 | 0.84 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$4.62 | -$11.29 | -6.67 | N/A | $0 |
| 05/01/2025 | Q1 2025 | -$4.80 | -$4.70 | 0.1 | N/A | $0 |
| 03/06/2025 | Q4 2024 | -$4.08 | -$4.97 | -0.89 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$4.20 | -$4.95 | -0.75 | N/A | $0 |
| 08/01/2024 | Q2 2024 | -$4.32 | -$6.61 | -2.29 | N/A | $0 |
| 05/02/2024 | Q1 2024 | -$5.40 | -$7.36 | -1.96 | N/A | $0 |
| 03/21/2024 | Q4 2023 | -$6.48 | -$6.22 | 0.26 | N/A | $0 |
| 11/02/2023 | Q3 2023 | -$7.68 | -$6.16 | 1.52 | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$7.20 | -$7.70 | -0.5 | N/A | $0 |
| 05/04/2023 | Q1 2023 | -$7.68 | -$6.95 | 0.73 | N/A | $0 |
| 03/02/2023 | Q4 2022 | -$7.80 | -$7.47 | 0.33 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$7.20 | -$8.18 | -0.98 | N/A | $0 |
| 08/04/2022 | Q2 2022 | -$8.76 | -$7.75 | 1.01 | N/A | $0 |
| 05/05/2022 | Q1 2022 | -$8.16 | -$8.92 | -0.76 | N/A | $0 |
| 03/03/2022 | Q4 2021 | -$8.04 | -$7.35 | 0.69 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$8.04 | -$7.79 | 0.25 | N/A | $0 |
| 08/05/2021 | Q2 2021 | -$7.20 | -$7.82 | -0.62 | N/A | $0 |
The conference call for Nextcure Inc's latest earnings report can be listened to online.
The conference call transcript for Nextcure Inc's latest earnings report can be read online.
Nextcure Inc (:NXTC) has a recorded net income of $-55,844,000.Nextcure Inc has generated $-19.65 earnings per share over the last four quarters.
Nextcure Inc (:NXTC) has a price-to-earnings ratio of -0.09 and price/earnings-to-growth ratio is -0.03.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED